COVID-19 Updates
From the Journals
No serious CV risks for elderly after Pfizer COVID-19 vaccine
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events...
Commentary
It feels like COVID is closing in
How can we as a psychiatric community get us through this pandemic?
Myth of the Super Doctor
COVID-19 and the immunocompromised physician
Beset with exhaustion and uncertainty, sacrifice has become a common thread that intrinsically united us against an unrelenting foe.
Latest News
COVID-19 antibody drug likely works against Omicron, companies say
The preliminary findings haven’t yet been peer-reviewed.
Feature
Ten changes that could keep clinicians in the workforce in a pandemic
Doctors make checklist of low-cost action items to start addressing a wave of providers leaving medicine.
Latest News
Second U.S. COVID-19 case caused by Omicron found
“This news is concerning, but it is not a surprise.”
Latest News
First Omicron variant case identified in U.S.
“All close contacts have been contacted and have tested negative.”
Latest News
Moderna warns of material drop in vaccine efficacy against Omicron
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
Latest News
Fauci: Omicron ‘very different from other variants’
“Although partial immune escape may occur, vaccines, particularly boosters, give a level of antibodies that even with variants like Delta give you...
FDA/CDC
FDA panel backs first pill for COVID-19 by a small margin
If authorized by the agency, molnupiravir would be first antiviral agent available as a pill to treat COVID-19.
Commentary
We physicians must pull together as a knowledge community
Intelligent, thoughtful, and highly respected scientists, researchers, and physicians must have room to safely share their knowledge and clinical...